课题基金 / 基金详情

FINDING NEW AVENUES TO OVERCOME CHEMORESISTANCE FOR IMPROVED CANCER THERAPY

FINDING NEW AVENUES TO OVERCOME CHEMORESISTANCE FOR IMPROVED CANCER THERAPY
寻找克服化疗耐药性以改善癌症治疗的新途径
批准号:
nhmrc : GNT1156095
负责人:
A/Pr Marco Herold
金额:
$64.92万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

A/Pr Marco Herold的其他基金

相似基金

相关文献

中文摘要
翻译
对于许多癌症患者来说,获得治愈或更长时间缓解的最大希望在于通过靶向细胞存活途径或以某种方式重新启动化疗反应来有效杀死肿瘤细胞的新药。我们的目标是开发能够中和促生存蛋白的新型小分子。此外,我们的目标是确定新的肿瘤抑制基因,其中一些可能代表癌症治疗的有吸引力的目标。
英文摘要
For many patients with cancer, the best hope for obtaining cures or much longer remission lies in new drugs that efficiently kill the tumour cells by targeting cell survival pathways or by somehow reinstalling chemotherapeutic response. We aim to develop novel small molecules able to neutralise pro-survival proteins. Furthermore, we aim to identify new tumour suppressor genes, some of which are likely to represent attractive targets for cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The mutagenic influence of 5-methylcytosine and its relevance for cancer treatment
Elucidating the cellular processes that are critical for p53 mediated tumour suppression
  • 批准号:
    nhmrc : GNT1143105
  • 项目类别:
    Project Grants
  • 资助金额:
    $101.61万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Marco Herold
  • 依托单位:
The mutagenic influence of 5-methylcytosine and its relevance for cancer treatment
  • 批准号:
    nhmrc : GNT1145912
  • 项目类别:
    Project Grants
  • 资助金额:
    $84.45万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Marco Herold
  • 依托单位:
Elucidating the cellular processes that are critical for p53 mediated tumour suppression
海外基金